(Q41637153)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9361959%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

review article

1 reference

title

Safety aspects of pegylated liposomal doxorubicin in patients with cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9361959%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

D S Alberts

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9361959%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D J Garcia

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9361959%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9361959%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9361959%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

54 Suppl 4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9361959%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

30-35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9361959%20AND%20SRC:MED&resulttype=core&format=json

Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma

7 November 2019

cites work

1 reference

12 December 2020

Anthracyclines in the treatment of cancer. An overview

1 reference

12 December 2020

Fatal hepatic failure with liposomal doxorubicin

1 reference

12 December 2020

Hepatic toxicity of liposomal encapsulated doxorubicin

1 reference

12 December 2020

Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome

1 reference

12 December 2020

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

1 reference

12 December 2020

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

1 reference

12 December 2020

Impact of scheduling on toxicity and clinical efficacy of doxorubicin: what do we know in the mid-nineties?

1 reference

12 December 2020

Lack of vesicant injury following extravasation of liposomal doxorubicin

1 reference

12 December 2020

Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study

1 reference

12 December 2020

Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours

1 reference

12 December 2020

Pharmacological-toxicological expert report. CAELYX. (Stealth liposomal doxorubicin HCl).

1 reference

12 December 2020

A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation

1 reference

12 December 2020

Doxorubicin (adriamycin) cardiomyopathy

1 reference

12 December 2020